• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大陆下一次新冠疫情大爆发的预测及其疫苗接种策略。

Prediction of the next major outbreak of COVID-19 in Mainland China and a vaccination strategy for it.

作者信息

Wu Yuanyuan, Zhou Weike, Tang Sanyi, Cheke Robert A, Wang Xia

机构信息

School of Mathematics and Statistics, Shaanxi Normal University, Xi'an 710119, People's Republic of China.

School of Mathematics, Northwest University, Xi'an 710127, People's Republic of China.

出版信息

R Soc Open Sci. 2023 Aug 30;10(8):230655. doi: 10.1098/rsos.230655. eCollection 2023 Aug.

DOI:10.1098/rsos.230655
PMID:37650063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10465198/
Abstract

After the widespread prevalence of COVID-19 at the end of 2022 in Mainland China, a major concern is when will the second major outbreak occur and with what prevalence and fatality rates will it be associated with, as peoples' immunity from natural infection subsides. To address this, we established an age-structured model considering vaccine and infection-derived immunity, fitted an immunity-waning curve, and calibrated the model using the epidemic and vaccination data from Hong Kong in 2022. The model and the situation of the first major epidemic in Mainland China were then used to predict the prevalence rate, fatality rate and peak time of the second wave. In addition, the controlling effects of different vaccination strategies on the second major outbreak are discussed. Finally, a characterization indicator for the level of population immunity was provided. We conclude that if the prevalence of the first major epidemic was 80%, the prevalence rate of the second major outbreak would be about 37.64%, and the peak time would have been July 2 2023. Strengthening vaccination can effectively delay the peak of the second wave of the epidemic and reduce the prevalence.

摘要

2022年底新冠病毒在中国大陆广泛流行后,一个主要担忧是随着人们自然感染产生的免疫力消退,第二次大规模疫情何时会发生,以及其相关的流行率和死亡率会是多少。为解决这个问题,我们建立了一个考虑疫苗和感染获得性免疫的年龄结构模型,拟合了免疫衰减曲线,并利用香港2022年的疫情和疫苗接种数据对模型进行了校准。然后,利用该模型和中国大陆首次大规模疫情的情况来预测第二波疫情的流行率、死亡率和峰值时间。此外,还讨论了不同疫苗接种策略对第二次大规模疫情的控制效果。最后,提供了一个人群免疫水平的表征指标。我们得出结论,如果第一次大规模疫情的流行率为80%,第二次大规模疫情的流行率将约为37.64%,峰值时间将是2023年7月2日。加强疫苗接种可以有效推迟第二波疫情的峰值并降低流行率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/9ee8046a07df/rsos230655f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/12697c95d1b8/rsos230655f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/b49f6cc725bb/rsos230655f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/689c7b5cf87f/rsos230655f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/9ee8046a07df/rsos230655f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/12697c95d1b8/rsos230655f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/b49f6cc725bb/rsos230655f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/689c7b5cf87f/rsos230655f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4254/10465198/9ee8046a07df/rsos230655f04.jpg

相似文献

1
Prediction of the next major outbreak of COVID-19 in Mainland China and a vaccination strategy for it.中国大陆下一次新冠疫情大爆发的预测及其疫苗接种策略。
R Soc Open Sci. 2023 Aug 30;10(8):230655. doi: 10.1098/rsos.230655. eCollection 2023 Aug.
2
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.中国存在免疫减弱和抗体依赖性增强(ADE)时 COVID-19 复燃风险的数学建模研究。
Vaccine. 2022 Nov 22;40(49):7141-7150. doi: 10.1016/j.vaccine.2022.10.043. Epub 2022 Oct 26.
3
Forecast for peak infections in the second wave of the Omicron after the adjustment of zero-COVID policy in the mainland of China.中国大陆调整疫情防控政策后奥密克戎毒株第二波感染高峰预测。
Infect Dis Model. 2023 May 30;8(2):562-573. doi: 10.1016/j.idm.2023.05.007. eCollection 2023 Jun.
4
Study on the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency.2022年11月至2023年1月中国大陆地区新冠疫情研究及其趋势预测
J Biosaf Biosecur. 2023 Mar;5(1):39-44. doi: 10.1016/j.jobb.2023.03.001. Epub 2023 Mar 22.
5
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States.美国针对奥密克戎BA.1变体的免疫力减弱和增强作用的数学评估。
Math Biosci Eng. 2023 Jan;20(1):179-212. doi: 10.3934/mbe.2023009. Epub 2022 Sep 30.
6
COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.2020 年中国内地不同地区的 COVID-19 疫情阶段和发病情况。
Front Public Health. 2023 Apr 6;11:1151038. doi: 10.3389/fpubh.2023.1151038. eCollection 2023.
7
Impacts of social distancing, rapid antigen test and vaccination on the Omicron outbreak during large temperature variations in Hong Kong: A modelling study.社交距离措施、快速抗原检测和疫苗接种对香港大温差期间奥密克戎疫情爆发的影响:一项建模研究。
J Infect Public Health. 2022 Dec;15(12):1427-1435. doi: 10.1016/j.jiph.2022.10.026. Epub 2022 Nov 4.
8
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.中国湖北省以外地区采取控制措施后第一波 COVID-19 的传染性和严重程度,以及第二波疫情情景规划:模型影响评估。
Lancet. 2020 Apr 25;395(10233):1382-1393. doi: 10.1016/S0140-6736(20)30746-7. Epub 2020 Apr 8.
9
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.建立模型以模拟巴基斯坦和阿富汗 2 型疫苗衍生脊髓灰质炎病毒暴发的传播情况,以在 COVID-19 大流行背景下为暴发控制策略提供信息。
Vaccine. 2023 Apr 6;41 Suppl 1:A93-A104. doi: 10.1016/j.vaccine.2021.09.037. Epub 2021 Sep 25.
10
SARS related preventive and risk behaviours practised by Hong Kong-mainland China cross border travellers during the outbreak of the SARS epidemic in Hong Kong.在香港严重急性呼吸系统综合症(SARS)疫情爆发期间,香港与中国内地跨境旅行者采取的与SARS相关的预防及风险行为。
J Epidemiol Community Health. 2004 Dec;58(12):988-96. doi: 10.1136/jech.2003.017483.

引用本文的文献

1
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
2
Associations between pre-infection serum vitamin D concentrations and Omicron COVID-19 incidence, severity and reoccurrence in elderly individuals.感染前血清维生素 D 浓度与老年人感染奥密克戎 COVID-19 的发病率、严重程度和再发率的关系。
Public Health Nutr. 2024 Oct 7;27(1):e197. doi: 10.1017/S1368980024001873.
3
Efficacy and prognostic factors of COVID-19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study.

本文引用的文献

1
Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA.基于年龄结构的数学模型对 COVID-19 早期大流行最优接种策略的研究:以美国为例。
Math Biosci Eng. 2023 Apr 19;20(6):10828-10865. doi: 10.3934/mbe.2023481.
2
PrEP Intervention in the Mitigation of HIV/AIDS Epidemics in China via a Data-Validated Age-Structured Model.基于数据验证的年龄结构模型对中国 HIV/AIDS 疫情缓解的 PrEP 干预
Bull Math Biol. 2023 Apr 11;85(5):41. doi: 10.1007/s11538-023-01145-4.
3
The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa.
COVID-19 疫苗在肝细胞癌患者中的疗效和预后因素:来自前瞻性队列研究的数据分析。
Cancer Med. 2024 Aug;13(15):e70068. doi: 10.1002/cam4.70068.
Delta 变异株的免疫逃逸能力与南非的 Beta 变异株相当。
BMC Public Health. 2023 Mar 17;23(1):511. doi: 10.1186/s12889-023-15431-2.
4
Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination.预测日本在免疫效果减弱和加强针接种情况下的 COVID-19 免疫景观。
J Theor Biol. 2023 Feb 21;559:111384. doi: 10.1016/j.jtbi.2022.111384. Epub 2022 Dec 14.
5
COVID-19 endgame: From pandemic to endemic? Vaccination, reopening and evolution in low- and high-vaccinated populations.COVID-19 终局:从大流行到地方病?低接种率和高接种率人群中的疫苗接种、重新开放和演变。
J Theor Biol. 2023 Feb 21;559:111368. doi: 10.1016/j.jtbi.2022.111368. Epub 2022 Nov 24.
6
Modelling the dynamics of infection, waning of immunity and re-infection with the Omicron variant of SARS-CoV-2 in Aotearoa New Zealand.奥密克戎变异株 SARS-CoV-2 在新西兰的感染动力学、免疫衰减和再感染建模。
Epidemics. 2022 Dec;41:100657. doi: 10.1016/j.epidem.2022.100657. Epub 2022 Nov 21.
7
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.中国存在免疫减弱和抗体依赖性增强(ADE)时 COVID-19 复燃风险的数学建模研究。
Vaccine. 2022 Nov 22;40(49):7141-7150. doi: 10.1016/j.vaccine.2022.10.043. Epub 2022 Oct 26.
8
Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection.生长分化因子15作为新型冠状病毒感染中一种新出现的生物标志物。
World J Methodol. 2022 Sep 20;12(5):438-447. doi: 10.5662/wjm.v12.i5.438.
9
Global stability and optimal control for a COVID-19 model with vaccination and isolation delays.具有疫苗接种和隔离延迟的COVID-19模型的全局稳定性和最优控制
Results Phys. 2022 Nov;42:106011. doi: 10.1016/j.rinp.2022.106011. Epub 2022 Sep 24.
10
Optimal vaccination strategies using a distributed model applied to COVID-19.使用分布式模型应用于新冠疫情的最优疫苗接种策略。
Cent Eur J Oper Res. 2023;31(2):499-521. doi: 10.1007/s10100-022-00819-z. Epub 2022 Sep 9.